The hydrophobically modified glycol chitosan (HGC) nanomicelle has received increasing
attention as a promising platform for the delivery of chemotherapeutic drugs. To improve the …

Polysaccharide-based nanogels have drawn considerable interest in pharmaceutics
because of their superior biocompatibility and potential responsiveness to external stimuli …

Understanding the intracellular distribution and trafficking of nanoparticle drug carriers is
necessary to elucidate their mechanisms of drug delivery and is helpful in the rational …

The aberrant expression of endocytic epidermal growth factor receptors (EGFRs) in cancer
cells has emerged as a key target for therapeutic intervention. Here, we describe for the first …

Conventional chemotherapy suffers lack of bioavailability, selectivity and multidrug
resistance (MDR). Nano-sized drug delivery systems (DDS) is developing aimed to solve …

A novel pH-responsive nanomicelle (QT-CA-CS) based on Chitosan, Quercetin and
Citraconic anhydride was reported in this study. The QT-CA-CS could self-assemble into …

Introduction: In the past decade, the glycol chitosan nanocarriers (GCNCs) have been
widely used for tumor-targeted delivery of anticancer agents such as chemo drugs, peptides …

Herein, we evaluated the cellular uptake pathways of hydrophobically modified glycol
chitosan (HGC) nanoparticles as nano‐sized drug carriers using cellular imaging …

Aim: This study aimed to explore an affordable technique for the fabrication of Chitosan
Nanoshuttles (CSNS) at the ultrafine nanoscale less than 100 nm with improved …

Hepatocellular carcinoma (HCC) is a malignant tumor leading cancer-associated high
mortality worldwide. Unfortunately, the most commonly used drug therapeutics not only lack …